Correlation of Campbell Score With Suicidal Ideation
Assessment of Campbell Score as a Means of Predicting Suicidal Ideation High Risk Patients
1 other identifier
observational
30
1 country
1
Brief Summary
The Campbell Score is a blood based means of assessing molecules believed to be associated with suicidal ideation and in some cases successful suicide. The current clinical trial will assess the Campbell Score in 3 groups: Group 1: 10 patients with no personal or family psychiatric history and no suicide attempts. Group 2: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported low acquired capability for suicide (Acquired Capability for Suicide Scale \<20). Group 3: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported high acquired capability for suicide (Acquired Capability for Suicide Scale \>60). The goal of the study is to confirm efficacy of Campbell Score in identifying patients with high suicidal ideation potential.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2020
CompletedFirst Posted
Study publicly available on registry
October 28, 2020
CompletedStudy Start
First participant enrolled
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2021
CompletedOctober 28, 2020
October 1, 2020
2 months
October 22, 2020
October 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Assessment of Campbell Score
Campbell Score will be compared between healthy volunteers, patients with suicidal idea with low acquired capability for suicide, and patients with suicidal idea with high acquired capability for suicide.
1 week to compare the records with the Campbell Score
Assessment of Correlation between Campbell Score and Beck Scale for Suicidal Ideation
Campbell Score will be compared to scoring of patients on the Beck Scale for Suicidal Ideation
1 week to compare the records with the Campbell Score
Study Arms (3)
Control Group
Subjects will have no personal or family psychiatric history and no suicide attempts.
Patients with Suicidal Ideation and Low Acquired Capability
Subjects will have suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported low acquired capability for suicide (Acquired Capability for Suicide Scale \<20)
Patients with Suicidal Ideation and High Acquired Capability
Subjects will have suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported high acquired capability for suicide (Acquired Capability for Suicide Scale \>60)
Interventions
The Campbell Score is a blood based assessment of inflammatory and immunologically associated markers that is currently in development as a means of predicting suicidal ideations.
Eligibility Criteria
The study population will comprise of 10 healthy volunteers, as well as 20 patients with suicidal ideations. 10 of the patients will have low acquired capability for suicide, and 10 will have high acquired capability for suicide.
You may qualify if:
- Capability of giving informed consent
- Agree to abide by the study protocol and its restrictions and be able to complete all aspects of the study.
- Be diagnosed with Suicide ideation/attempts/gestures
You may not qualify if:
- \- Not currently pregnant or lactating (due to potential confounding of brain activity as a result of differing hormone levels)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Therapeutic Solutions International
Oceanside, California, 92056, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2020
First Posted
October 28, 2020
Study Start
November 5, 2020
Primary Completion
January 13, 2021
Study Completion
February 13, 2021
Last Updated
October 28, 2020
Record last verified: 2020-10